{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T20:23:25Z","timestamp":1774902205105,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry and Physics of Lipids"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.chemphyslip.2021.105086","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T13:39:57Z","timestamp":1619530797000},"page":"105086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["A study to enhance the oral bioavailability of s-adenosyl-l-methionine (SAMe): SLN and SLN nanocomposite particles"],"prefix":"10.1016","volume":"237","author":[{"given":"Gulin","family":"Amasya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9387-0085","authenticated-orcid":false,"given":"Ahmet Dogan","family":"Ergin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozge","family":"Erkan Cakirci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9142-9061","authenticated-orcid":false,"given":"Arif Tanju","family":"Oz\u00e7elikay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0386-7887","authenticated-orcid":false,"given":"Zerrin","family":"Sezgin Bayindir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8907-9741","authenticated-orcid":false,"given":"Nilufer","family":"Yuksel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.chemphyslip.2021.105086_bib0005","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ejpb.2014.03.009","article-title":"Spray freeze drying for dry powder inhalation of nanoparticles","volume":"87","author":"Ali","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2019.03.056","article-title":"QbD guided early pharmaceutical development study: production of lipid nanoparticles by high pressure homogenization for skin cancer treatment","volume":"563","author":"Amasya","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0015","first-page":"107","article-title":"Lipid nanoparticulate drug delivery systems: a revolution in dosage form design and development","volume":"5","author":"Attama","year":"2012","journal-title":"Recent Adv. Novel Drug Carrier Systems"},{"issue":"12","key":"10.1016\/j.chemphyslip.2021.105086_bib0020","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/jnnp.53.12.1096","article-title":"Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine","volume":"53","author":"Bottiglieri","year":"1990","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"4","key":"10.1016\/j.chemphyslip.2021.105086_bib0025","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1208\/s12248-017-0085-5","article-title":"Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system","volume":"19","author":"Bou-Chacra","year":"2017","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.chemphyslip.2021.105086_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.31887\/DCNS.2002.4.1\/bbondy","article-title":"Pathophysiology of depression and mechanisms of treatment","volume":"4","author":"Brigitta","year":"2002","journal-title":"Dialogues Clin. Neurosci."},{"issue":"10-11","key":"10.1016\/j.chemphyslip.2021.105086_bib0035","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.addr.2011.05.017","article-title":"Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles","volume":"63","author":"Cai","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.chemphyslip.2021.105086_bib0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ejpb.2013.07.017","article-title":"Solid lipid particles for oral delivery of peptide and protein drugs I\u2013elucidating the release mechanism of lysozyme during lipolysis","volume":"85","author":"Christophersen","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.chemphyslip.2021.105086_bib0045","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jcmgh.2018.12.002","article-title":"The intestinal lymphatic system: functions and metabolic implications","volume":"7","author":"Cifarelli","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.chemphyslip.2021.105086_bib0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.chemphyslip.2021.105086_bib0055","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1208\/s12249-010-9563-0","article-title":"Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery","volume":"12","author":"Das","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0060","series-title":"Other Common Mental Disorders: Global Health Estimates","first-page":"1","author":"Depression, WHO","year":"2017"},{"issue":"2","key":"10.1016\/j.chemphyslip.2021.105086_bib0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ddtec.2011.12.001","article-title":"Overcoming poor oral bioavailability using nanoparticle formulations\u2013opportunities and limitations","volume":"9","author":"Desai","year":"2012","journal-title":"Drug Discov. Today Technol."},{"issue":"3","key":"10.1016\/j.chemphyslip.2021.105086_bib0070","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jpba.2005.01.041","article-title":"Evaluation of chemical and diastereoisomeric stability of S-adenosylmethionine in aqueous solution by capillary electrophoresis","volume":"38","author":"Desiderio","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2020.104953","article-title":"Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections","volume":"232","author":"Dudhipala","year":"2020","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0080","article-title":"A novel delivery system for enhancing bioavailability of S-adenosyl-L-methionine: pectin nanoparticles-in-microparticles and their in vitro \u2013 in vivo evaluation","volume":"61","author":"Ergin","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0085","series-title":"Guidance for Industry: Bioavailability Studies Submitted in NDAs or INDs \u2014 General Sonsiderations","author":"FDA","year":"2019"},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0090","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.2147\/IJN.S178077","article-title":"Microfluidization trends in the development of nanodelivery systems and applications in chronic disease treatments","volume":"13","author":"Ganesan","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0095","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1023\/A:1016039819247","article-title":"Quantitative determination of crystallinity of \u03b1-lactose monohydrate by DSC","volume":"68","author":"Gomb\u00e1s","year":"2002","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: a review emphasizing on particle structure and drug release","volume":"133","author":"Gordillo-Galeano","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0105","first-page":"60","article-title":"Q2A text on validation of analytical procedures","author":"Guideline","year":"1994","journal-title":"Fed. Regist."},{"issue":"2","key":"10.1016\/j.chemphyslip.2021.105086_bib0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.carres.2004.11.026","article-title":"Crystallization and X-ray diffraction of spray-dried and freeze-dried amorphous lactose","volume":"340","author":"Haque","year":"2005","journal-title":"Carbohydr. Res."},{"issue":"1-2","key":"10.1016\/j.chemphyslip.2021.105086_bib0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijpharm.2007.05.066","article-title":"Effect of the microencapsulation of nanoparticles on the reduction of burst release","volume":"344","author":"Hasan","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.chemphyslip.2021.105086_bib0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/j.2051-5545.2010.tb00298.x","article-title":"Pathophysiology of depression: do we have any solid evidence of interest to clinicians?","volume":"9","author":"Hasler","year":"2010","journal-title":"World Psychiatry"},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/9781118444726.ch4","article-title":"Solid lipid nanoparticles for drug delivery","author":"Joseph","year":"2013","journal-title":"Drug Delivery Strategies Poorly Water-Soluble Drugs"},{"issue":"6","key":"10.1016\/j.chemphyslip.2021.105086_bib0130","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/jps.20075","article-title":"Combined application of parallel artificial membrane permeability assay and Caco\u20102 permeability assays in drug discovery","volume":"93","author":"Kerns","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0135","first-page":"2733","article-title":"Advanced drug delivery to the lymphatic system: lipid-based nanoformulations","volume":"8","author":"Khan","year":"2013","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.chemphyslip.2021.105086_bib0140","first-page":"222","article-title":"Nano-colloidal carrier via polymeric coating for oral delivery of isradipine","volume":"9","author":"Kumar","year":"2017","journal-title":"Interv. Med. Appl. Sci."},{"issue":"12","key":"10.1016\/j.chemphyslip.2021.105086_bib0145","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.2042-7158.1972.tb08930.x","article-title":"Letters to the Editor: linearization of dissolution rate curves by the Weibull distribution","volume":"24","author":"Langenbucher","year":"1972","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.chemphyslip.2021.105086_bib0150","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jad.2011.04.059","article-title":"Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder","volume":"136","author":"Levkovitz","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.chemphyslip.2021.105086_bib0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nano.2012.05.019","article-title":"Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA","volume":"9","author":"Lin","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.chemphyslip.2021.105086_bib0160","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/10717544.2017.1279238","article-title":"pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms","volume":"24","author":"Liu","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0165","unstructured":"MacDonald, I.D., Harrison, N., Takacs-Cox, A., Purac, A., Blazek-Welsh, A. 2011. U.S. Patent Application No. 12\/845,555."},{"issue":"1","key":"10.1016\/j.chemphyslip.2021.105086_bib0170","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ijpharm.2015.09.014","article-title":"Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach","volume":"495","author":"Makwana","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.chemphyslip.2021.105086_bib0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nmat1812","article-title":"Stiffer by design","volume":"6","author":"Manias","year":"2007","journal-title":"Nat. Mater."},{"issue":"3","key":"10.1016\/j.chemphyslip.2021.105086_bib0180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14227\/DT180311P15","article-title":"Simulated biological fluids with possible application in dissolution testing","volume":"18","author":"Marques","year":"2011","journal-title":"Dissolution Technol."},{"issue":"5","key":"10.1016\/j.chemphyslip.2021.105086_bib0185","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1211\/0022357056082","article-title":"S\u2010adenosyl\u2010L\u2010methionine: transcellular transport and uptake by Caco\u20102 cells and hepatocytes","volume":"57","author":"McMillan","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"64","author":"Mehnert","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.chemphyslip.2021.105086_bib0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-4165(02)00333-1","article-title":"Stabilization of S-adenosyl-L-methionine promoted by trehalose","volume":"1573","author":"Morana","year":"2002","journal-title":"Biochimica et Biophysica Acta (BBA)-General Subjects"},{"issue":"4","key":"10.1016\/j.chemphyslip.2021.105086_bib0200","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: a modern formulation approach in drug delivery system","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.chemphyslip.2021.105086_bib0205","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-5173(96)04731-X","article-title":"Biodegradation of solid lipid nanoparticles as a function of lipase incubation time","volume":"144","author":"M\u00fcller","year":"1996","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.chemphyslip.2021.105086_bib0210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0215","series-title":"From Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs","first-page":"334","article-title":"In vitro degradation assay for solid lipid nanoparticles","author":"Olbrich","year":"1998"},{"issue":"1","key":"10.1016\/j.chemphyslip.2021.105086_bib0220","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0378-5173(98)00404-9","article-title":"Enzymatic degradation of SLN\u2014effect of surfactant and surfactant mixtures","volume":"180","author":"Olbrich","year":"1999","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.chemphyslip.2021.105086_bib0225","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/appi.ajp.2009.09081198","article-title":"S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial","volume":"167","author":"Papakostas","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.chemphyslip.2021.105086_bib0230","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2478\/v10007-012-0040-z","article-title":"Solid lipid based nanocarriers: an overview","volume":"62","author":"Pardeshi","year":"2012","journal-title":"Acta Pharm."},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0235","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jddst.2017.02.013","article-title":"Development of efavirenz loaded solid lipid nanoparticles: risk assessment, quality-by-design (QbD) based optimisation and physicochemical characterisation","volume":"39","author":"Raina","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2020.105005","article-title":"Tailoring lipid nanoconstructs for the oral delivery of paliperidone: formulation, optimization and in vitro evaluation","volume":"234","author":"Rehman","year":"2021","journal-title":"Chem. Phys. Lipids"},{"issue":"2-3","key":"10.1016\/j.chemphyslip.2021.105086_bib0245","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0168-3659(01)00354-6","article-title":"Lipid microparticles as a parenteral controlled release device for peptides","volume":"73","author":"Reithmeier","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0250","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.lwt.2015.11.008","article-title":"Enhanced curcumin permeability by SLN formulation: the PAMPA approach","volume":"66","author":"Righeschi","year":"2016","journal-title":"LWT-Food Sci. Technol."},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111305","article-title":"Solid lipid nanoparticles for enhanced oral absorption: a review","volume":"196","author":"Salah","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"4","key":"10.1016\/j.chemphyslip.2021.105086_bib0260","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ceat.200406111","article-title":"High\u2010pressure homogenization as a process for emulsion formation","volume":"27","author":"Schultz","year":"2004","journal-title":"Chem. Eng. Technol."},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0265","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/750891","article-title":"Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery","volume":"2012","author":"Severino","year":"2012","journal-title":"J. Drug Deliv."},{"issue":"6","key":"10.1016\/j.chemphyslip.2021.105086_bib0270","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4088\/JCP.16r11113","article-title":"S-Adenosylmethionine (SAMe) for neuropsychiatric disorders: a clinician-oriented review of research","volume":"78","author":"Sharma","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.chemphyslip.2021.105086_bib0275","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1248\/cpb.58.650","article-title":"Formulation and evaluation of solid lipid nanoparticles of a water-soluble drug: zidovudine","volume":"58","author":"Singh","year":"2010","journal-title":"Chem. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.chemphyslip.2021.105086_bib0280","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/02652040600612439","article-title":"Polymorphic behaviour of Compritol\u00ae 888 ATO as bulk lipid and as SLN and NLC","volume":"23","author":"Souto","year":"2006","journal-title":"J. Microencapsul."},{"issue":"2","key":"10.1016\/j.chemphyslip.2021.105086_bib0285","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0378-5173(98)00110-0","article-title":"Optimization of in vitro nifedipine penetration enhancement through hairless mouse skin","volume":"169","author":"Squillante","year":"1998","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.chemphyslip.2021.105086_bib0290","first-page":"289","article-title":"Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives","volume":"2","author":"\u00dcner","year":"2007","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.chemphyslip.2021.105086_bib0295","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/00914037.2019.1570513","article-title":"Development and evaluation of Eudragit coated environmental sensitive solid lipid nanoparticles using central composite design module for enhancement of oral bioavailability of linagliptin","volume":"69","author":"Veni","year":"2020","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"issue":"1","key":"10.1016\/j.chemphyslip.2021.105086_bib0300","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijpharm.2015.08.074","article-title":"Polymer nanocomposite particles of S-nitrosoglutathione: a suitable formulation for protection and sustained oral delivery","volume":"495","author":"Wu","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.chemphyslip.2021.105086_bib0305","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7150\/ijms.7.398","article-title":"Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer","volume":"7","author":"Yassin","year":"2010","journal-title":"Int. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.chemphyslip.2021.105086_bib0310","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3109\/10717544.2016.1153744","article-title":"Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus","volume":"23","author":"Yu","year":"2016","journal-title":"Drug Deliv."},{"issue":"1-2","key":"10.1016\/j.chemphyslip.2021.105086_bib0315","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-5173(00)00554-8","article-title":"Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and-independent methods","volume":"209","author":"Yuksel","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2021.105086_bib0320","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejpb.2016.10.021","article-title":"Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery","volume":"110","author":"Zoubari","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.chemphyslip.2021.105086_bib0325","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013drug release and release mechanism","volume":"45","author":"zur M\u00fchlen","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Chemistry and Physics of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308421000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308421000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:32:43Z","timestamp":1757860363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009308421000396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":65,"alternative-id":["S0009308421000396"],"URL":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2021.105086","relation":{},"ISSN":["0009-3084"],"issn-type":[{"value":"0009-3084","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A study to enhance the oral bioavailability of s-adenosyl-l-methionine (SAMe): SLN and SLN nanocomposite particles","name":"articletitle","label":"Article Title"},{"value":"Chemistry and Physics of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2021.105086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105086"}}